A. Rost

A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Marcus Schmidt, J. Huober, H. Lück, 2010, BMC Cancer.

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma.

D. Hoelzer, G. Seipelt, P. Mitrou, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.

D. Jaeger, S. Al-Batran, S. Hahnfeld, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial

R. Hofheinz, R. Hehlmann, D. Buchheidt, 2000, Oncology Research and Treatment.

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

M. Hansmann, S. Al-Batran, M. Welslau, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

Hartmut Link, Michael Scholz, Thomas Kirchner, 2014, The Lancet. Oncology.

Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer

F. Opri, L. Edler, M. Koldehoff, 1998, Oncology Research and Treatment.

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

H. Einsele, W. Gesierich, A. Hinke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial

W. Scheithauer, V. Heinemann, J. Holch, 2018, International journal of cancer.

Phase II Study of a Weekly 24-Hour Infusion with 5-Fluorouracil and Simultaneous Sodium – Folinic Acid in the First-Line Treatment of Metastatic Colorectal Cancer

R. Hofheinz, A. Wein, E. Kreuser, 2001, Oncology Research and Treatment.

Phase-II-study of a 24-h infusion with 5-fluorouracil (5-FU) and simultaneous sodium-folinic acid in the first-line-treatment of advanced colorectal cancer: interim analysis

R. Hofheinz, A. Wein, E. Kreuser, 1999 .